What is a digital health application (DiGA)?
A DiGA is an app, or more generally an IT application, that medical staff can prescribe. Colloquially, these applications are therefore often called "apps on prescription". Unlike simple "health apps", which have been available in large numbers in app stores for years, DiGA have been through an extensive official approval process and are consequently listed in the statutory health insurance (GKV) benefits catalogue as low-risk medical devices (class 1 or 2a under the European Medical Device Regulation, MDR). The advantage for patients is therefore that the applications can be prescribed by medical staff (like medicines) and the resulting costs are covered in full by the statutory health insurance funds. For an overview, all prescribable apps can also be found in the so-called DiGA directory, available online on the website of the Federal Institute for Drugs and Medical Devices (BfArM).
The fast-track approval process
A manufacturer's route into the BfArM's DiGA directory as a verified, reimbursable application depends on successfully completing the so-called "fast-track" procedure. For this, manufacturers submit an application in which they must provide information on meeting various DiGA requirements. In addition to details of any positive healthcare effects already demonstrated, these include requirements on safety, functionality and quality, but also on interoperability, data protection and information security.
Involving SDG
Annexes I and II of the so-called DiGA Ordinance (DiGAV) contain more than 80 items or statements on data protection and security-related questions in total, all of which must be answered when the application is submitted. Data protection experts are already familiar with the topics from the GDPR or from ISO standards: they cover the usual principles, legal bases and information obligations of the GDPR as well as questions on system hardening, access control and the implementation of an information security management system (ISMS). Important points include:
- An ISMS under BSI 200-2 or alternatively under ISO 27001 has been mandatory for DiGA approval since 2 January 2022!
- DiGA approval imposes much more restrictive data protection requirements than a look at the GDPR alone would suggest. In the case of third-country transfers, for example, the use of Art. 46 and 47 GDPR (standard contractual clauses and binding corporate rules) is completely excluded. Since there has also been no adequacy decision under Art. 45 for the USA since mid-2020, personal data in connection with a DiGA may under no circumstances be processed by companies based there or by their EU subsidiaries.
- Because health data is personal data of a special category under Art. 9 GDPR, DiGA manufacturers must analyse, assess, reduce or even eliminate the risks associated with processing this data by means of a so-called data protection impact assessment (DPIA) under Art. 35 GDPR.